Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 41-50 of 66 for CHRONIC LYMPHOCYTIC LEUKEMIA

Edit search filters
  1. A Study To Evaluate The Safety And Efficacy Of BGB-16673 Compared To Pirtobrutinib In Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. A Study To Evaluate The Safety And Effectiveness Of JBH492 In Patients With Chronic Lymphocytic Leukemia And Non-Hodgkin's Lymphoma

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. Lenalidomide In Improving Immune Response To Vaccine Therapy In Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Or Monoclonal B Cell Lymphocytosis

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study To Evaluate The Safety And Tolerability Of KTE-X19 In Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia And Small Lymphocytic Lymphoma

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. A Study To Assess The Effectiveness And Safety Of Ublituximab In Combination With Umbralisib And Venetoclax (U2-V) Compared To Ublituximab And Umbralisib (U2) In Subjects With Chronic Lymphocytic Leukemia (CLL)

    Jacksonville, FL, Rochester, MN

  6. A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

    Scottsdale/Phoenix, AZ

  7. A Study To Define Axl Expression Level In Skin Biopsy Specimens From Patients With Skin Cancer In Relation To Chronic Lymphocytic Leukemia

    Rochester, MN

  8. A Study To Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib In Adults With Previously Untreated Chronic Lymphocytic Leukemia

    Jacksonville, FL, Rochester, MN

  9. A Study To Evaluate The Efficacy And Safety Of Lenalidomide As Maintenance Therapy For Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy

    Jacksonville, FL

  10. Elevate CLL R/R: Study Of Acalabrutinib (ACP-196) Versus Ibrutinib In Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer